Suppr超能文献

标准化报告疾病负担研究:STROBOD 声明。

Standardised reporting of burden of disease studies: the STROBOD statement.

机构信息

Health Information, Department of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsman 14, 1050, Brussels, Belgium.

Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

出版信息

Popul Health Metr. 2024 Oct 7;22(1):28. doi: 10.1186/s12963-024-00347-9.

Abstract

BACKGROUND

The burden of disease (BOD) approach, originating with the Global Burden of Disease (GBD) study in the 1990s, has become a cornerstone for population health monitoring. Despite the widespread use of the Disability-Adjusted Life Year (DALY) metric, variations in methodological approaches and reporting inconsistencies hinder comparability across studies. To tackle this issue, we set out to develop guidelines for reporting DALY calculation studies to improve the transparency and comparability of BOD estimates.

METHODS AND FINDINGS

The development of the STROBOD statement began within the European Burden of Disease Network, evolving from initial concepts discussed in workshops and training sessions focused on critical analysis of BOD studies. In 2021, a working group was formed to refine the preliminary version into the final Standardised Reporting of Burden of Disease studies (STROBOD) statement, consisting of 28 items structured across six main sections. These sections cover the title, abstract, introduction, methods, results, discussion, and open science, aiming to ensure transparency and standardization in reporting BOD studies. Notably, the methods section of the STROBOD checklist encompasses aspects such as study setting, data inputs and adjustments, DALY calculation methods, uncertainty analyses, and recommendations for reproducibility and transparency. A pilot phase was conducted to test the efficacy of the STROBOD statement, highlighting the importance of providing clear explanations and examples for each reporting item.

CONCLUSIONS

The inaugural STROBOD statement offers a crucial framework for standardizing reporting in BOD research, with plans for ongoing evaluation and potential revisions based on user feedback. While the current version focuses on general BOD methodology, future iterations may include specialized checklists for distinct applications such as injury or risk factor estimation, reflecting the dynamic nature of this field.

摘要

背景

疾病负担(BOD)方法起源于 20 世纪 90 年代的全球疾病负担(GBD)研究,已成为人口健康监测的基石。尽管残疾调整生命年(DALY)指标得到广泛应用,但方法学方法的差异和报告的不一致性阻碍了研究之间的可比性。为了解决这个问题,我们着手制定报告 DALY 计算研究的指南,以提高 BOD 估计的透明度和可比性。

方法和发现

STROBOD 陈述的制定始于欧洲疾病负担网络内,最初的概念是在专注于 BOD 研究批判性分析的研讨会和培训课程中讨论的。2021 年,成立了一个工作组,将初步版本细化为最终的标准化疾病负担研究报告(STROBOD)陈述,由 28 个项目组成,分为六个主要部分。这些部分涵盖标题、摘要、引言、方法、结果、讨论和开放科学,旨在确保 BOD 研究报告的透明度和标准化。值得注意的是,STROBOD 清单的方法部分包括研究设置、数据输入和调整、DALY 计算方法、不确定性分析以及可重复性和透明度的建议等方面。进行了试点阶段以测试 STROBOD 陈述的功效,强调了为每个报告项目提供清晰解释和示例的重要性。

结论

开创性的 STROBOD 陈述为 BOD 研究的报告提供了一个重要的框架,计划根据用户反馈进行持续评估和潜在修订。虽然当前版本侧重于一般的 BOD 方法,但未来的迭代可能包括针对特定应用(如伤害或风险因素估计)的专门清单,反映了该领域的动态性质。

相似文献

4
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

引用本文的文献

9

本文引用的文献

4
The Burden of Disease in Germany at the National and Regional Level.德国的国家和地区疾病负担
Dtsch Arztebl Int. 2022 Nov 18;119(46):785-792. doi: 10.3238/arztebl.m2022.0314.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验